Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More

07-1294 Anti-phospho-VEGFR2/Flk-1/KDR (Tyr1223) Antibody

This Anti-phospho-VEGFR2/Flk-1/KDR (Tyr1223) Antibody is validated for use in WB for the detection of phospho-VEGFR2/Flk-1/KDR (Tyr1223).

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Signaling Gene Symbol: KDR, VEGFR-2, VEGFR2, VEGFR, CD309, FLK1, EC 2.7.10.1 UniProt Number: P35968
07-1294
100 µL  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Specifications Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
M, R, Pm, Ca, B, Po, EqWBRbAffinity PurifiedPolyclonal Antibody
Description
Catalogue Number07-1294
Trade Name
  • Upstate
DescriptionAnti-phospho-VEGFR2/Flk-1/KDR (Tyr1223) Antibody
Alternate Names
  • Kinase insert domain receptor
  • Protein-tyrosine kinase receptor Flk-1
  • kinase insert domain receptor (a type III receptor tyrosine kinase)
  • vascular endothelial growth factor receptor 2
Background InformationThe Flt gene family of receptor tyrosine kinases includes Flt-1, KDR/Flk-1, Flt-3, and Flt-4. They encode receptors for VEGF, characterized by seven Ig-loops within their extracellular domain and a split kinase domain within the cytoplasmic domain. VEGF is an important angiogenic factor of many solid tumors and is also involved in the differentiation of endothelial cells. Flt-1 (Fms-like tyrosine kinase, VEGF-R1) is expressed on endothelial cells and on the common precursors of endothelial and hematopoietic stem cells. KDR (Flk-1, VEGF-R2) is the principal receptor involved in VEGF signaling. KDR is expressed on endothelial cells and stimulates angiogenesis, but is also expressed on bone marrow cells, and is thought to play a role in driving the proliferation of most or all leukemic cells. Flt3 is a class III receptor tyrosine kinase that is closely related to c-Kit and c-Fms. It is expressed in primitive hematopoietic cells and its ligand exerts proliferative effects on these cells in co-operation with other cytokines. The VEGF receptors stimulate the Ras-MAP kinase pathway, suggesting that it signals as a conventional receptor tyrosine kinase.
References
Product Information
FormatAffinity Purified
Control
  • CSF-1 treated PAE cell lysate, transfected with CSF/KDR.
PresentationDouble affinity purified rabbit polyclonal in PBS with 0.05% NaN3 and 50% glycerol.
Applications
ApplicationThis Anti-phospho-VEGFR2/Flk-1/KDR (Tyr1223) Antibody is validated for use in WB for the detection of phospho-VEGFR2/Flk-1/KDR (Tyr1223).
Key Applications
  • Western Blotting
Biological Information
ImmunogenSynthetic peptide encompassing phosphorylated Tyr1223 of human VEGFR2.
HostRabbit
SpecificityRecognizes VEGFR2/Flk-1/KDR when phosphorylated on Tyrosine 1223 (human).
Species Reactivity
  • Mouse
  • Rat
  • Primate
  • Canine
  • Bovine
  • Pig
  • Horse
Species Reactivity NoteHuman tested. Expected to react with Mouse, Rat, Primate, Canine, Cow, Pig, Horse, based on sequence homolgy.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Gene Symbol
  • KDR
  • VEGFR-2
  • VEGFR2
  • VEGFR
  • CD309
  • FLK1
  • EC 2.7.10.1
Modifications
  • Phosphorylation
Purification MethodDual Antigen Affinity purification
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P35968 # Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
SIZE: 1356 amino acids; 151527 Da
SUBUNIT: Interacts with SHB upon VEGF activation. Interacts with HIV-1 Tat.
SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
SIMILARITY: SwissProt: P35968 ## Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. & Contains 7 Ig-like C2-type (immunoglobulin-like) domains. & Contains 1 protein kinase domain. ...
Molecular Weight152 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceWestern Blot Analysis:
This lot detected VEGFR2 phosphorylated on Tyr1223 at a 1:1,000 dilution in PAE cells transfected with CSF/KDR and treated with 40ng/mL CSF-1 for 15 min. Cell lysate resolved via SDS-PAGE and transferred to PVDF (Immobilon-P).
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalog Number GTIN
07-1294 04053252514470

Related Products & Applications

Related Products

Catalog Number Description
04-894 Anti-phospho-KDR/Flk-1/VEGFR2 (Tyr1054) Antibody, clone D1W, rabbit monoclonal
05-554 Anti-KDR/Flk-1/VEGFR2 Antibody, clone CH-11
07-374 Anti-phospho-KDR/Flk-1/VEGFR2 (Tyr1214) Antibody
07-722 Anti-phospho-VEGFR2/Flk-1/KDR (Tyr1054) Antibody
ABS553 Anti-phospho KDR/FLK-1/VEGFR2 Antibody (Tyr1059)

Product Families

Endothelial Cell Markers

The thin layer of cells that lines the interior surface of blood vessels and lymphatic vessels, forming an interface between circulating blood or lymph in the lumen and the rest of the vessel wall.
Learn More >>

Categories

Life Science Research > Antibodies and Assays > Primary Antibodies